These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 470929)

  • 1. Structural and stereochemical requirements for muscarinic receptor binding.
    Aronstam RS; Triggle DJ; Eldefrawi ME
    Mol Pharmacol; 1979 Mar; 15(2):227-34. PubMed ID: 470929
    [No Abstract]   [Full Text] [Related]  

  • 2. Muscarinic activity and receptor binding of the enantiomers of aceclidine and its methiodide.
    Ringdahl B; Ehler FJ; Jenden DJ
    Mol Pharmacol; 1982 May; 21(3):594-9. PubMed ID: 6125875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decrease in (3H)-quinuclidinyl bezilate binding to the muscarinic cholinergic receptor in the longitudinal muscle of the rat ileum following chronic administration of diisopropylfuorophosphate.
    Ehlert FJ; Kokka N
    Proc West Pharmacol Soc; 1977; 20():1-7. PubMed ID: 896813
    [No Abstract]   [Full Text] [Related]  

  • 4. Molecular requirements of the active sites of the cholinergic receptors. XIX-Size evaluation of the muscarinic subsite.
    Gualtieri F; Brasili L; Giannella M; Pigini M
    Farmaco Sci; 1982 Sep; 37(9):618-26. PubMed ID: 7128816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemical studies on muscarinic receptors.
    Massoulié J; Godwin S; Carson S; Kato G
    Biomedicine; 1977 Jul; 26(4):250-9. PubMed ID: 579159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Structure-activity relationship in the series of muscarinic acetylcholine receptor agonists: three types of agonist-receptor complexes].
    Tropsha AE; Nizhniĭ SV; Iaguzhinskiĭ LS
    Bioorg Khim; 1985 Oct; 11(10):1391-401. PubMed ID: 4074399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inversion of stereospecificity by methylation of compounds acting at acetylcholine receptors.
    Barlow RB; Casy AF
    Mol Pharmacol; 1975 Sep; 11(5):690-3. PubMed ID: 1080832
    [No Abstract]   [Full Text] [Related]  

  • 8. Characterization of muscarinic cholinergic receptors in the lower esophageal sphincter of the cat: binding of [3H]quinuclidinyl benzilate.
    Rimele TJ; Rogers WA; Gaginella TS
    Gastroenterology; 1979 Dec; 77(6):1225-34. PubMed ID: 499710
    [No Abstract]   [Full Text] [Related]  

  • 9. Muscarinic receptor binding in the parotid gland. Different affinities of some anticholinergic drugs between the parotid gland and ileum.
    Nilvebrant L; Sparf B
    Scand J Gastroenterol Suppl; 1982; 72():69-77. PubMed ID: 6957999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biochemical indentification of the mammalian muscarinic cholinergic receptor.
    Snyder SH; Chang KJ; Kuhar MJ; Yamamura HI
    Fed Proc; 1975 Sep; 34(10):1915-21. PubMed ID: 808430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Structure- and conformation-activity relationship of heterocyclic acetylcholine analogs. 13. Cholinergic properties of tertiary and quaternary 4-acetoxyquinuclidines].
    Lambrecht G
    Arzneimittelforschung; 1982; 32(2):130-4. PubMed ID: 7199915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cooperativity pattern in the interaction of the antiestrogen drug clomiphene with the Muscarinic receptors.
    Ben-Baruch G; Schreiber G; Sokolovsky M
    Mol Pharmacol; 1982 Mar; 21(2):287-93. PubMed ID: 7099137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cholinergic muscarinic receptor in synaptosomal membranes. Heterogeneity of binding sites for L-[3H]quinuclidinyl benzilate.
    Aguilar JS; Salas PJ; De Robertis E
    Mol Pharmacol; 1982 Sep; 22(2):304-9. PubMed ID: 7144732
    [No Abstract]   [Full Text] [Related]  

  • 14. The binding of agonists to brain muscarinic receptors.
    Birdsall NJ; Burgen AS; Hulme EC
    Mol Pharmacol; 1978 Sep; 14(5):723-36. PubMed ID: 714021
    [No Abstract]   [Full Text] [Related]  

  • 15. Sites of action of phencyclidine. III. Interactions with muscarinic receptors.
    Aronstam RS; Eldefrawi ME; Eldefrawi AT; Albuquerque EX; Jim KF; Triggle DJ
    Mol Pharmacol; 1980 Sep; 18(2):179-84. PubMed ID: 7421791
    [No Abstract]   [Full Text] [Related]  

  • 16. Biochemical characterization of the muscarinic cholinergic receptor in human brain: alterations in Huntington's disease.
    Wastek GJ; Yamamura HI
    Mol Pharmacol; 1978 Sep; 14(5):768-80. PubMed ID: 152407
    [No Abstract]   [Full Text] [Related]  

  • 17. Interaction of phencyclidine and its new adamantyl derivatives with muscarinic receptors.
    Gabrielevitz A; Kloog Y; Kalir A; Balderman D; Sokolovsky M
    Life Sci; 1980 Jan; 26(2):89-95. PubMed ID: 7366325
    [No Abstract]   [Full Text] [Related]  

  • 18. Antimuscarinic oxotremorine analogs distinguish high and low affinity agonist states of muscarinic receptors.
    Ringdahl B; Amstutz R; Closse A
    Proc West Pharmacol Soc; 1988; 31():57-60. PubMed ID: 3211922
    [No Abstract]   [Full Text] [Related]  

  • 19. Evidence for muscarinic receptors on rat colonic epithelial cells: binding of [3H]quinuclidinyl benzilate.
    Rimele TJ; O'Dorisio MS; Gaginella TS
    J Pharmacol Exp Ther; 1981 Aug; 218(2):426-34. PubMed ID: 7252842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A theoretical and experimental study of the semirigid cholinergic agonist 3-acetoxyquinuclidine.
    Weinstein H; Maayani S; Srebrenik S; Cohen S; Sokolovsky M
    Mol Pharmacol; 1975 Sep; 11(5):671-89. PubMed ID: 1177874
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.